Tumor fraction and copy number burden from urinary cell-free tumor DNA (utDNA) to predict minimal residual disease prior to repeat-transurethral resection in high-risk non-muscle invasive bladder cancer (HR-NMIBC)

被引：0
|
作者：
Linscott, Joshua
Miyagi, Hiroko
Gould, Billie
Murthy, Prithvi
Rose, Kyle M.
Camperlengo, Lucia P.
Bonora, Giancarlo
Zemp, Logan
Gilbert, Scott Michael
Spiess, Philippe E.
Sexton, Wade J.
Meeks, Joshua J.
Du, Pan
Jia, Shidong
Li, Roger
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[2] Predicine Inc, Hayward, CA USA
[3] Oschner Med Ctr, Jefferson, LA USA
[4] Predicine, Hayward, CA USA
[5] H Lee Moffitt Canc Ctr & Res Inst, Dept Genitourinary Oncol, Tampa, FL USA
[6] Northwestern Univ, Dept Urol, Feinberg Sch Med, Chicago, IL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4600
引用
收藏
页数：1
相关论文
共 22 条
  • [1] Cell-free urinary tumor DNA to detect minimal residual disease prior to repeat-transurethral resection of bladder tumor in non-muscle invasive bladder cancer: A prospective study
    Rose, Kyle M.
    Murthy, Prithvi
    Gould, Billie
    Huelster, Heather L.
    Davaro, Facundo
    Camperlengo, Lucia P.
    Du, Pan
    Jia, Shidong
    Vosoughi, Aram
    Grass, G. Daniel
    Spiess, Philippe E.
    Gilbert, Scott Michael
    Sexton, Wade J.
    Li, Roger
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [2] DETECTING RESIDUAL TUMOR WITH CELL-FREE URINARY TUMOR DNA IN HIGH-RISK NON-MUSCLE INVASIVE BLADDER CANCER PATIENTS
    Linscott, Joshua
    Miyagi, Hiro
    Gould, Billie
    Murthy, Prithvi
    Du, Pan
    Jia, Shidong
    Li, Roger
    JOURNAL OF UROLOGY, 2024, 211 (05): : E988 - E988
  • [3] Combination therapy in high-risk non-muscle invasive bladder cancer (HR-NMIBC) with and without BCG prior treatment
    Rexer, H.
    Ohlmann, C. -H.
    Grimm, M. -O.
    UROLOGIE, 2023, 62 (03): : 338 - 339
  • [4] Cell-free urinary tumor DNA to detect minimal residual disease prior to repeattransurethral resection of bladder tumor in non-muscle-invasive bladder cancer: A prospective study.
    Rose, Kyle M.
    Murthy, Prithvi
    Gould, Billie
    Huelster, Heather L.
    Davaro, Facundo
    Du, Pan
    Jia, Shidong
    Li, Roger
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [5] Tumor mutational burden (TMB) and BCG responsiveness in high-risk non-muscle invasive bladder cancer (NMIBC).
    Bastos, Diogo Assed
    Lima, Mariana
    Mattedi, Romulo Loss
    dos Santos, Filipe Ferreira
    Buzatto, Vanessa
    Barreiro, Rodrigo
    Ribeiro-Filho, Leopoldo
    Cordeiro, Mauricio
    Amano, Mariane
    Souza, Jussara Michaloski
    Bettoni, Fabiana
    Favoretto Galante, Pedro Alexandre
    Dzik, Carlos
    Nahas, William Carlos
    Camargo, Anamaria Aranha
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [6] Tumor mutation burden to predict progression in high-risk non-muscle invasive bladder cancer.
    Meeks, Joshua
    Carneiro, Benedito A.
    Pai, Sachin Gopalkrishn
    Oberlin, Daniel
    Rademaker, Alfred
    Fedorchak, Kyle
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [7] Prognostic significance of residual tumor at restaging transurethral bladder resection in high-risk non-muscle-invasive bladder cancer
    Guigui, Alexandre
    Basile, Giuseppe
    Zattoni, Fabio
    Gallioli, Andrea
    Verri, Paolo
    Aumatell, Julia
    Gondran-Tellier, Bastien
    Lechevallier, Eric
    Bastide, Cyrille
    Uleri, Alessandro
    Sica, Michele
    Long-Depaquit, Thibaut
    Dinoi, Giuseppe
    Moro, Fabrizio Dal
    Akiki, Akram
    Toledano, Harry
    Rajwa, Pawel
    Montorsi, Francesco
    Amparore, Daniele
    Porpiglia, Francesco
    Breda, Alberto
    Moschini, Marco
    Baboudjian, Michael
    WORLD JOURNAL OF UROLOGY, 2024, 42 (01)
  • [8] COMPARATIVE ANALYSIS OF METHYLATION BIOMARKERS IN TUMOR AND URINARY TUMOR DNA IN HIGH-RISK NON-MUSCLE INVASIVE BLADDER CANCER PATIENTS
    Miyagi, Hiroko
    Linscott, Joshua
    Gould, Billie
    Du, Pan
    Jia, Shidong
    Li, Roger
    JOURNAL OF UROLOGY, 2024, 211 (05): : E991 - E991
  • [9] Tumor mutational burden (TMB), intratumoral genetic heterogeneity (ITGH) and BCG responsiveness in high-risk non-muscle invasive bladder cancer (NMIBC).
    Bastos, Diogo Assed
    Lima, Mariana
    Mattedi, Romulo Loss
    Dzik, Carlos
    Ribeiro-Filho, Leopoldo
    Cordeiro, Mauricio
    Nahas, William Carlos
    Souza, Jussara Michaloski
    Amano, Mariane
    Bettoni, Fabiana
    Buzatto, Vanessa
    dos Santos, Filipe Ferreira
    Barreiro, Rodrigo
    Favoretto Galante, Pedro Alexandre
    Camargo, Anamaria Aranha
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [10] Predictors of residual tumor at re-staging transurethral resection for high-risk non-muscle invasive bladder cancer: Insights from a large multi-institutional collaboration
    Claps, F.
    Pavan, N.
    D'Altilia, N.
    Checcucci, E.
    Napolitano, L.
    Morlacco, A.
    Tafuri, A.
    Palumbo, C.
    Boeri, L.
    Tulone, G.
    Bignu, C.
    Liguori, G.
    Busetto, G. M.
    Simonato, A.
    Montanari, E.
    Carmignani, L.
    Celia, A.
    Volpe, A.
    Antonelli, A.
    Dal Moro, F.
    Mirone, V
    Porpiglia, F.
    Cormio, L.
    Carrieri, G.
    Trombetta, C.
    EUROPEAN UROLOGY, 2022, 81 : S232 - S233
123